SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dale w ruckle who wrote (474)4/27/1998 10:44:00 PM
From: Saracen  Read Replies (1) of 1185
 
Having been a shareholder for a long time, I know that Dr. Walker and his UBC gang struggled through the first few years of Nortran's existence, never quite having enough capital at their disposal. And what they did raise almost always seemed to be too little, too late. As such, when somebody now comes to Dr. Walker offering fresh capital (and I believe that this is what happened), he finds it very difficult to refuse.

Also, one of my broker's tells me that it was Dr. Walker who sold the 1 million+ block of stock last Monday at $2.15, and so I would not be surprised to see at least some of this cash being recycled into the just-announced financing deal. If he is a true believer in Nortran's potential (which I am sure he is), then why wouldn't he be willing to sell free-trading stock without warrants, in exchange for restricted stock with warrants? I wish I had the option to do the same.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News